Predict your next investment

Venture Capital
aberdare.com

See what CB Insights has to offer

Investments

118

Portfolio Exits

26

Funds

6

About Aberdare Ventures

Aberdare Ventures focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies.

Aberdare Ventures Headquarter Location

One Embarcadero Center Suite 4000

San Francisco, California, 94111,

United States

(415) 392-7442

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Aberdare Ventures News

Press Release: Gravie Raises $14.1 Million in Series C Funding

Jul 19, 2017

Gravie, provider of a reinvented health benefits marketplace, today announced a $14.1M Series C funding round led by new investor GE Ventures with participation from existing investors, including FirstMark Capital , Aberdare Ventures and Split Rock Partners . This investment brings the total raised by the company to over $44M since 2013.“We’re excited to have GE Ventures as an investor as we continue on our journey of improving health benefits for employers and consumers,” said Abir Sen , co-founder and CEO. “This funding enables us to continue on our path of rapid growth and help employers and consumers get better healthcare.” As part of the financing, Lisa Suennen , Senior Managing Director at GE Ventures will join Gravie’s Board of Directors. “At GE Ventures, we scale ideas and grow companies that advance industries and improve lives,” says Suennen. “We are thrilled to partner with Gravie as they bring to market a much needed innovative, user-friendly approach to employee benefits.” About Gravie With smart technology and a human touch, Gravie is reinventing health benefits, making them easier and more affordable for employers and employees. Founded in 2013, Gravie today serves over 900 employers and over 62,000 individuals across the United States.

Aberdare Ventures Investments

118 Investments

Aberdare Ventures has made 118 investments. Their latest investment was in Intrinsic Exchange Group as part of their Series A on September 9, 2021.

CBI Logo

Aberdare Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/14/2021

Series A

Intrinsic Exchange Group

Yes

1

5/15/2019

Unattributed VC - III

Oak Street Health

$1.5M

No

1

11/8/2018

Series E

MC10

$10.03M

No

1

10/19/2018

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

5/21/2018

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/14/2021

5/15/2019

11/8/2018

10/19/2018

5/21/2018

Round

Series A

Unattributed VC - III

Series E

Unattributed VC - II

Series C - II

Company

Intrinsic Exchange Group

Oak Street Health

MC10

Subscribe to see more

Subscribe to see more

Amount

$1.5M

$10.03M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Aberdare Ventures Portfolio Exits

26 Portfolio Exits

Aberdare Ventures has 26 portfolio exits. Their latest portfolio exit was Sonitus Technologies on October 05, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/5/2021

Acquired

$99M

1

11/30/2020

Reverse Merger

$99M

1

8/6/2020

IPO

$99M

Public

3

1/24/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/1/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/5/2021

11/30/2020

8/6/2020

1/24/2020

1/1/2020

Exit

Acquired

Reverse Merger

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

1

3

10

10

Aberdare Ventures Fund History

6 Fund Histories

Aberdare Ventures has 6 funds, including Aberdare Ventures IV LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2008

Aberdare Ventures IV LP

Early-Stage Venture Capital

Closed

$150M

1

9/6/2005

Aberdare Ventures III LP

Subscribe to see more

Subscribe to see more

$99M

10

1/1/2001

Aberdare Ventures II LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/1999

Aberdare Ventures LP

Subscribe to see more

Subscribe to see more

$99M

10

Aberdare II Annex Fund LP

Subscribe to see more

Subscribe to see more

10

Closing Date

12/31/2008

9/6/2005

1/1/2001

12/31/1999

Fund

Aberdare Ventures IV LP

Aberdare Ventures III LP

Aberdare Ventures II LP

Aberdare Ventures LP

Aberdare II Annex Fund LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$150M

$99M

$99M

$99M

Sources

1

10

10

10

10

Aberdare Ventures Team

3 Team Members

Aberdare Ventures has 3 team members, including current Controller, Christina Fong.

Name

Work History

Title

Status

Christina Fong

Controller

Current

Paul Klingenstein

Managing Partner

Current

Brett Battles

General Partner

Former

Name

Christina Fong

Paul Klingenstein

Brett Battles

Work History

Title

Controller

Managing Partner

General Partner

Status

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.